MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14737167.2026.2743886

Медицинская библиотека · Expert review of pharmacoeconomics & outcomes research · 2026

Cost-effectiveness of microaxial flow pump versus standard of Care in the management of Cardiogenic shock in Spain.

Andrea Rut, Jurado-Román Alfonso, Rosillo Sandra O, Bustamante-Munguira Juan, Diaz Jose F, Crespo-Leiro Maria Generosa, González-Alonso Del Hoyo Rocío, Oyagüez Itziar, Garcia Nuria, Foux Lorine, Tsintzos Stylianos, Presa Maria

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Cardiogenic shock (CS) remains the leading cause of death in patients with ST-elevation myocardial infarction (STEMI) despite timely revascularization and advances in pharmacological therapy. This study assessed the cost-effectiveness of a microaxial flow pump (mAFP) plus standard of care (SoC) versus SoC alone in patients with STEMI complicated by CS from the perspective of the Spanish National Health System (NHS).

RESEARCH DESIGN AND

METHODS

A cost-effectiveness analysis was conducted using a partitioned survival model over a lifetime horizon. Clinical efficacy inputs were derived from DanGer Shock trial, while adverse and long-term clinical events were obtained from DanGer Shock and literature. Direct healthcare costs (expressed in 2025 euros), including device acquisition, hospitalization, adverse and clinical events management, and cardiac rehabilitation.

RESULTS

In the base-case analysis, mAFP+SoC yielded 3.430 life-years gained (LYG) and 2.645 quality-adjusted life-years (QALY) per patient, compared with 1.657 LYG and 1.272 QALYs with SoC alone. Total costs were €51,980 and €17,008, respectively, resulting in an incremental cost-utility ratio of 25,468/QALY. Deterministic and probabilistic sensitivity analyses supported model robustness.

CONCLUSIONS

From the Spanish NHS perspective, mAFP+SoC could be a cost-effective strategy for STEMI-CS, providing substantial gains in survival and health-related quality of life at a reasonable incremental cost.

Для цитирования: Andrea Rut, Jurado-Román Alfonso, Rosillo Sandra O, Bustamante-Munguira Juan, Diaz Jose F, Crespo-Leiro Maria Generosa, González-Alonso Del Hoyo Rocío, Oyagüez Itziar, Garcia Nuria, Foux Lorine, Tsintzos Stylianos, Presa Maria. Cost-effectiveness of microaxial flow pump versus standard of Care in the management of Cardiogenic shock in Spain.. Expert review of pharmacoeconomics & outcomes research. 2026. DOI: 10.1080/14737167.2026.2743886.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.